Fewer Adults Eligible for Statins With PREVENT Equations
By Elana Gotkine HealthDay Reporter
FRIDAY, June 21, 2024 -- Use of the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations reduces the number of adults meeting criteria for primary prevention statin therapy compared with use of the 2013 pooled cohort equations (PCEs), according to a study published online June 10 in JAMA Internal Medicine.
Timothy S. Anderson, M.D., from the University of Pittsburgh, and colleagues conducted a cross-sectional study involving adults aged 40 to 75 years who participated in the National Health and Nutrition Examination Survey from 2017 to March 2020. National estimates of 10-year atherosclerotic cardiovascular disease (ASCVD) risk were compared using the 2013 PCEs and the PREVENT equations, developed in 2023.
The researchers found that 20.7 percent of the weighted sample of 3,785 U.S. adults without known ASCVD reported current statin use. The mean estimated 10-year ASCVD risk was 8.0 and 4.3 percent using the PCEs and PREVENT equations, respectively. Compared with the PCEs, the mean estimated 10-year ASCVD risk was lower using the PREVENT equations across all age, sex, and racial subgroups, with the largest difference seen for Black adults (10.9 versus 5.1 percent) and those aged 70 to 75 years (22.8 versus 10.2 percent). The number of adults meeting criteria for primary prevention statin therapy would be reduced from 45.4 to 28.3 million with use of the PREVENT equations instead of the PCEs. Based on the PREVENT equations, 44.1 percent of adults eligible for primary prevention statin therapy reported currently taking statins.
"Use of the PREVENT equations could result in 17.3 million patients no longer meeting criteria for primary prevention statin therapy," the authors write. "However, the majority of adults eligible for receiving such therapy based on PREVENT equations are not currently receiving statins."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Survival Improves With Open Hysterectomy for Cervical Cancer
FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical...
Precision-Guided Treatment Improves Outcomes for High-Risk Pediatric Cancer
FRIDAY, June 28, 2024 -- Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June 6 in Nature Medicine. Loretta...
Recommendations Issued for Advanced Imaging for Pediatric Patients in ED
THURSDAY, June 27, 2024 -- In a policy statement issued by the American Academy of Pediatrics and published online June 27 in Pediatrics, recommendations are presented for...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.